Demonstration of a Legacy Application's Path to Exascale - ASC L2 Milestone 4467.
Abstract not provided.
SEARCH · Search NASA
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Abstract not provided.
Abstract not provided.
Abstract not provided.
Explore the source record for details and available documents.
Abstract not provided.
Abstract not provided.
Idaho National Laboratory (INL) has developed and tested engineered sorbents to separate and capture volatile fission products such iodine (I), xenon (Xe), and krypton (Kr) from off-gas streams. As noble gases, Xe and Kr can be difficult to capture and separate. Historically, cryogenic distillation has been used to execute the separation, but this method can pose significant hazards. INL has successfully developed two sorbents for Xe and Kr capture, silver mordenite polyacrylonitrile (AgZ-PAN) and hydrogen mordenite polyacrylonitrile (HZ-PAN). Adsorption studies to date successfully separated and captured Xe from carrier gas streams, but those studies focused primarily on initial separation and capture. In addition, the ability to concentrate Xe through multiple adsorption and desorption cycles has not been studied and therefore is the focus on this presentation. Concentrating Xe during desorption is ideal to produce Xe that can be used for commercial and research applications.
No abstract prepared.
No abstract prepared.
Highlights: Black-Right-Pointing-Pointer We immortalized human adipose stromal cells (ASCs) with hTERT, Bmi-1, and SV40T. Black-Right-Pointing-Pointer hTERT-only ASCs are prone to transformation, while Bmi-only ASCs become senescent. Black-Right-Pointing-Pointer SV40T introduced along with hTERT abrogates proliferation control and multipotency. Black-Right-Pointing-Pointer hTERT combined with Bmi-1 yields stable phenotype up to 140 population doublings. -- Abstract: Adipose tissue-derived stromal cells (ASCs) are increasingly being studied for their usefulness in regenerative medicine. However, limited life span and donor-dependent variation of primary cells such as ASCs present major hurdles to controlled and reproducible experiments. We therefore aimed to establish immortalized ASC cell lines that provide steady supply of homogeneous cells for in vitro work while retain essential features of primary cells. To this end, combinations of human telomerase reverse transcriptase (hTERT), murine Bmi-1, and SV40 large T antigen (SV40T) were introduced by lentiviral transduction into ASCs. The resulting cell lines ASC{sup hTERT}, ASC{sup Bmi-1}, ASC{sup Bmi-1+hTERT} and ASC{sup SV40T+hTERT} were tested for transgene expression, telomerase activity, surface immunomarkers, proliferation, osteogenic and adipogenic differentiation, karyotype, tumorigenicity, and cellular senescence. All cell lines have maintained expression of characteristic surface immunomarkers, and none was tumorigenic. However, ASC{sup Bmi-1} had limited replicative potential, while the rapidly proliferating ASC{sup SV40T+hTERT} acquired chromosomal aberrations, departed from MSC phenotype, and lost differentiation capacity. ASC{sup hTERT} and ASC{sup hTERT+Bmi-1}, on the other hand, preserved all essential MSC features and did not senesce after 100 population doublings. Notably, a subpopulation of ASC{sup hTERT} also acquired aberrant karyotype and showed signs of transformation after long-term culture. In conclusion, hTERT alone was sufficient to extend the life span of human ASC, but ASC{sup hTERT} are prone to transformation during extensive subculturing. The combination of Bmi-1 and hTERT successfully immortalized human ASCs without significantly perturbing their phenotype or biological behavior.
The B cell response to influenza infection of the respiratory tract contributes to viral clearance and establishes profound resistance to reinfection by related viruses. Numerous studies have measured virus-specific antibody-secreting cell (ASC) frequencies in different anatomical compartments after influenza infection and provided a general picture of the kinetics of ASC formation and dispersion. However, the dynamics of ASC populations are difficult to determine experimentally and have received little attention. Here, we applied mathematical modeling to investigate the dynamics of ASC growth, death, and migration over the 2-week period following primary influenza infection in mice. Experimental data for model fitting came from high frequency measurements of virus-specific IgM, IgG, and IgA ASCs in the mediastinal lymph node (MLN), spleen, and lung. Model construction was based on a set of assumptions about ASC gain and loss from the sampled sites, and also on the directionality of ASC trafficking pathways. Most notably, modeling results suggest that differences in ASC fate and trafficking patterns reflect the site of formation and the expressed antibody class. Essentially all early IgA ASCs in the MLN migrated to spleen or lung, whereas cell death was likely the major reason for IgM and IgG ASC loss from the MLN. In contrast, the spleen contributed most of the IgM and IgG ASCs that migrated to the lung, but essentially none of the IgA ASCs. This finding points to a critical role for regional lymph nodes such as the MLN in the rapid generation of IgA ASCs that seed the lung. Results for the MLN also suggest that ASC death is a significant early feature of the B cell response. Overall, our analysis is consistent with accepted concepts in many regards, but it also indicates novel features of the B cell response to influenza that warrant further investigation.
A greenhouse experiment was conducted to evaluate the growth and heavy-metal accumulation of Brassica chinensis and Agropyron elongatum in 10 and 25% ash-sludge co-compost (ASC)-amended loamy acidic soil (pH 4.51) at two different application rates: 20% and 40% (v/v). Soil pH increased, whereas electrical conductivity decreased with the amendment of ASC to soil. Bioavailable Cu, Zn, and Mn contents of ASC-amended soil decreased, whereas Ni, Pb, and B contents increased. Concentrations of bioavailable Cu, Zn, and Mn in sludge compost (SC)-amended soils were 5.57, 20.8, and 8.19 mg kg{sup -1}, respectively. These concentrations were significantly lower than those in soil receiving an application rate of 20 or 25% ASC as 2.64, 8.48, and 5.26 mg kg(-1), respectively. Heavy metals and B contents of the composting mass significantly increased with an increase in ASC application rate from 20 to 40% (6.2 to 16.6 mg kg{sup -1} for 10% ASC- and 9.4 to 18.6 mg kg{sup -1} for 25% ASC-amended soil. However, when the ash content in co-compost increased from 10 to 25% during composting, bioavailable heavy-metal contents decreased. However, B contents increased with an increase in ash content. Addition of co-composts increased the dry-weight yield of the plants, and this increase was more obvious as the ash amendment rate in the co-composts and the ASC application rate increased. In case of B. chinensis, the biomass of 2.84 g/plant for 40% application of 25% ASC was significantly higher than SC (0.352 g/plant), which was 40% application of 10% ASC (0.434 g/plant) treatments. However, in A. elongatum, the differences between biomass of plants grown with 10% (1.34-1.94 g/ plant) and 25% ASC (2.12-2.21 g/plant) were not significantly different. ASC was favorable in increasing the growth of B. chinensis and A. elongatum. The optimal ash amendment to the sludge composting and ASC application rates were at 25 and 20%, respectively.
Highlights: • PGE2 was remarkably increased in conditioned media from THP-1 co-cultured with ASCs. • ASCs induced M1 to M2 macrophage transition through PGE2. • ASCs suppressed secretion of inflammatory IL-1β and IL-18 through PGE2. • ASCs ameliorated colitis by decreasing the total number of macrophages. • ASCs relieved inflammation by decreasing the M1 macrophage population. Inflammatory bowel disease (IBD) is an idiopathic disease caused by a dysregulated immune response to intestinal microbes in an individual with a genetic predisposition. Therefore, alleviation of inflammation is very important to treat IBD. Mesenchymal stem cells (MSCs) have been highlighted as new candidates for treating autoimmune disease based on their immunomodulatory properties. In this study, we investigated the anti-inflammatory mechanism and therapeutic effects of adipose tissue-derived MSCs (ASCs) using THP-1 macrophages and dextran sodium sulfate (DSS)-induced mice with chronic colitis. LPS-treated THP-1 cells expressed mRNA of CD11b, an M1 macrophage marker, at day 2. However, THP-1 co-cultured with ASCs expressed mRNA of CD206, CD68, CCL18, legumain, and IL-10, markers of M2 macrophages. In THP-1 cells co-cultured with ASCs, precursor (pro)-IL-1β, Cox-2, and NLRP3 increased dramatically compared to LPS-treated THP-1 cells. Secretion of IL-1β and IL-18 was significantly inhibited by ASCs, but PGE2 production was highly increased in co-culture conditions of THP-1 and ASCs. IL-18 secretion was inhibited by PGE2 treatment, and PGE2 inhibited inflammasome complex (ASC/Cas-1/NLRP3) formation in THP-1 cells. In the DSS-induced chronic colitis model, ASCs ameliorated colitis by decreasing the total number of macrophages and the M1 macrophage population. Our results suggest that ASCs can suppress the inflammatory response by controlling the macrophage population, and ASCs may be therapeutically useful for the treatment of IBD.